Loading
A phase 3 trial of Plerixafor and Filgrastim in Multiple myeloma, run by Case Comprehensive Cancer Center, recorded as terminated on the registry.
Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide is a phase 3 interventional study registered as NCT01301963 by Case Comprehensive Cancer Center, with 9 participants recorded, started 2011-07 and due to reach its primary completion in 2013-06. Interventions recorded: plerixafor, filgrastim. Conditions recorded: Refractory Multiple Myeloma.
Linked to the drug Plerixafor because the registry names it among its interventions and Multiple myeloma among its conditions. Registry record only: no result has been read by an editor.
Shares Plerixafor, Filgrastim (G-CSF) and the tag pipeline.
Shares Plerixafor, Multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma, Multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma, Multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma, Multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma, Multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma, Multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma, Multiple myeloma and the tag pipeline.